Bio Europe Spring, Paris, France

38th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

EVER 2019, Nice (FR)

GenSight Biologics to present new GS010 data at the 2019 Annual Meeting of the American Academy of Ophthalmology

2019 Annual Meeting ASRS, Chicago, IL (US)

2019 SOE Congress, European Society of Ophthalmology, Nice, France

GenSight Biologics announces positive Data Safety Monitoring Board review and continuation of PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa

Sonoma Eye 2019, Sonoma, CA

9th EURETINA Winter Meeting, Prague, Czech Republic

GenSight Biologics enrolls first subject in first-in-man PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa